The size of the Empty Capsules Market in North America is estimated to grow USD 813.79 million by 2027 and USD 613.88 million in 2022, growing at a CAGR of 5.80% during the forecast period.
The expansion of the pharmaceutical industry, increased R&D efforts and clinical trial studies, and advancements in capsule delivery methods are all driving the growth of the empty capsules market in North America. Empty capsules are in more demand due to the rising emphasis on better pharmaceutical goods and generics. A rise in the popularity of capsules over alternative drug delivery forms, as well as an increase in strategic alliances between empty capsule providers and gelatin producers, is driving market expansion. In addition, as the population grows, the need for various treatment medicines and nutritional supplements to improve health outcomes grows. Furthermore, because capsules are the most popular solid oral dose form, the nutraceutical business in this region has a significant need for empty capsules.
Pharmaceutical companies are making record investments in this region, creating lucrative market expansion opportunities. The rising prevalence of non-communicable illnesses such as cancer, diabetes, heart disease, and lung problems has increased the demand for nutraceuticals. In addition, during the COVID-19 pandemic, personal health has become more prominent in the minds of a huge portion of the population. This pattern has set the nutraceutical sector up for further growth and success in the coming years. Chronic illnesses, which are becoming more common as the population of older individuals grows, impose a significant demand on the development of therapeutically effective medicines to treat them. Solid capsules are favored by the elderly for several reasons: they are simple to ingest and decrease the quicker dissolving times and gastrointestinal stimulation generated by these galenic formulations when compared to oral dosage forms.
The growth of the North American empty capsules market is likely to be hampered by ethical concerns, price fluctuations in gelatin materials, and stringent regulations in the pharmaceutical industry. In addition, North America's supply chain for gelatin capsules is likely to be significantly disrupted owing to transportation restrictions at various nations' borders throughout the world, which is expected to hamper the region's market expansion.
The expansion of this industry is challenged by growing commodity prices and cultural and religious concerns about the use of capsules containing inactive components of animal origin, such as pork capsules and bovine gelatin envelopes.
This research report on the North America Empty Capsules Market has been segmented and sub-segmented into the following categories:
By Product:
By Therapeutic Application:
By End User:
By Country:
Regionally, North America is the largest market for Empty capsules in the global market. Within North America, the United States is the largest market due to rising consumer awareness. The North American region's dominance may be attributable to significant capsule producers with huge production capabilities and several pharmaceutical giants with large manufacturing capacities that use these capsules. The growing demand for capsule-based nutraceutical formulations accounts for the majority of this region's share. There has been an increase in the consumption of this nutraceutical since they aid in the prevention of significant health problems such as obesity, cancer, and arthritis. The rising burden of chronic illnesses and the expanding elderly population in the United States are thought to be the main driver of the analyzed market's expansion in North America. Furthermore, the United States and Canada have well-developed and well-structured healthcare systems. These platforms also encourage research and development.
KEY MARKET PLAYERS:
A few of the noteworthy companies operating in the North American Empty Capsules Market profiled in this report are Capsugel, ACG Worldwide, Suheung Co Ltd., Bright Pharmacaps Inc., Capscanada Corporation, Medi-Caps Ltd., Qualicaps, Roxlor, LLC, Snail Pharma Industry Co.Ltd. and Sunil Healthcare Limited.
Related Reports
Access the study in MULTIPLE FORMATS
Purchase options starting from $ 2000
Call us on: +1 888 702 9696 (U.S Toll Free)
Write to us: sales@marketdataforecast.com